Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Más filtros

Tipo del documento
Intervalo de año de publicación
1.
Artículo en Inglés | MEDLINE | ID: mdl-34894478

RESUMEN

Leishmania genus is responsible for leishmaniasis, a group of diseases affecting 12 million people in the tropical and subtropical zone. Currently, the few drugs that are available to treat this disease are expensive and cause many side effects. Searching for new therapeutics from plant species seems to be a promising path. This work proposes an original HPTLC test against parasites, in particular on Leishmania infantum, to screen new molecules from plant extracts. The technique uses protozoa transformed to express the luciferase gene to observe the bioautogram in bioluminescence. We have developed two different test protocols based on the two dimorphic stages of the parasite. The free promastigote stage, and an intracellular stage parasitizing macrophage cells called the amastigote stage. These two stages only survive under extremely different conditions which required the development of two very different test protocols. For the promastigote free stage of the protozoa, the direct bioautography technique was chosen while for the intracellular amastigote stage, bioautography by immersion (agar overlay) was required. Amphotericine B was chosen as the reference compound for this assay. The development of each of these two tests made it possible to clearly detect areas of activity on the bioautogram, allowing a rapid and inexpensive screening of the antiparasitic properties of molecules in natural extracts.


Asunto(s)
Bioensayo/métodos , Cromatografía en Capa Delgada/métodos , Leishmania infantum/efectos de los fármacos , Extractos Vegetales , Tripanocidas , Humanos , Estadios del Ciclo de Vida/efectos de los fármacos , Extractos Vegetales/análisis , Extractos Vegetales/química , Extractos Vegetales/farmacología , Células THP-1 , Tripanocidas/análisis , Tripanocidas/química , Tripanocidas/farmacología
2.
J Pharm Biomed Anal ; 164: 475-480, 2019 Feb 05.
Artículo en Inglés | MEDLINE | ID: mdl-30472581

RESUMEN

A new high performance liquid chromatography (HPLC) method has been established for quantitative and qualitative analysis of three tetracyclic iridoids: ML-2-3 (1), molucidin (2), and ML-F52 (3), which are responsible for anti-trypanosomal and anti-leishmanial activities of Morinda lucida Bentham leaves. Separation of 1-3 from dried 80% aqueous (aq.) ethanol extract was achieved on a reversed-phase cholester column packed with cholesteryl-bonded silica using an acetonitrile-0.1% aq. formic acid mobile phase system. Ultraviolet-visible (UV-VIS) spectroscopy was employed for detection of compounds, and their contents were determined by measuring absorbance at 254 nm. Depending on the above system, several factors potentially affecting the concentration of tetracyclic iridoids were evaluated resulting in several variation on plant organs, seasonality, variation between individual trees, and branch positions within the trees. Moreover, we developed a simple, quick, and effective method for tetracyclic iridoid isolation from M. lucida leaves that consisted of extraction by sonication into 80% aq. ethanol, basic hydrolysis, acid neutralization, liquid-liquid extraction into an organic solvent, and reverse phase open column chromatography. Employing this method, we have succeeded to obtain 1 as a colorless crystal yielding of 0.23%, which was 28 times higher than that of previous isolation method. Setting up methodology in this paper may be important for future in vitro and in vivo studies of tetracyclic iridoids and moreover for their applications in new drug design and development.


Asunto(s)
Fraccionamiento Químico/métodos , Iridoides/farmacología , Morinda/química , Extractos Vegetales/farmacología , Tripanocidas/farmacología , Fraccionamiento Químico/instrumentación , Cromatografía Líquida de Alta Presión/instrumentación , Cromatografía Líquida de Alta Presión/métodos , Diseño de Fármacos , Iridoides/análisis , Iridoides/química , Iridoides/aislamiento & purificación , Extractos Vegetales/análisis , Extractos Vegetales/química , Hojas de la Planta/química , Investigación Cualitativa , Solventes/química , Tripanocidas/análisis , Tripanocidas/química , Tripanocidas/aislamiento & purificación , Trypanosoma/efectos de los fármacos
3.
Rev. bras. plantas med ; 18(2): 415-422, 2016. tab
Artículo en Portugués | LILACS | ID: lil-787949

RESUMEN

RESUMO O objetivo deste estudo foi avaliar o efeito antibacteriano e tripanocida in vitro do extrato hidroalcóolico das raízes de Tradescantia sillamontana Matuda (Commelinaceae), conhecida popularmente como veludo branco. Foi avaliada a atividade antibacteriana in vitro frente às bactérias Streptococcus mitis (CIM = 100 µg/mL; CMB = 150 µg/mL), Streptococcus mutans (CIM = 200 µg/mL; CMB = 220 µg/mL), Streptococcus sanguinis (CIM = 400 µg/mL; CMB = 425 µg/mL), Streptococcus sobrinus (CIM = 400 µg/mL; CMB = 420 µg/mL) e Bacteroides fragilis (CIM = 400 µg/mL; CMB = 430 µg/mL) pelo método de diluição em caldo. Os protozoários da família tripanossomatídeo causam doenças tropicais que costumam ser negligenciadas que costumam ser como a tripanossomíase, para a qual estão disponíveis poucos medicamentos. Neste contexto, o extrato hidroalcóolico das raízes de T. sillamontana também foi avaliado frente às formas tripomastigotas da cepa Y de Trypanosoma cruzi, com promissora atividade frente a este protozoário (IC50 = 2,4 µg/mL). Quando avaliada a atividade citotóxica frente a fibroblastos da linhagem LLCMK2, o extrato apresentou moderada citotoxicidade (CC50 = 480,37 µg/mL). Os resultados ora apresentados para o extrato hidroalcóolico das raízes de Tradescantia sillamontana Matuda demonstraram promissoras atividades antibacteriana e tripanocida, sendo uma fonte alternativa de produtos naturais com atividades contra T. cruzi e algumas bactérias do gênero Streptococcus e Bacteroides.


ABSTRACT The aim of this study was to investigate the in vitro, antibacterial and trypanocidal effect of the hydroalcoholic extract from the roots of Tradescantia sillamontana Matuda (Commelinaceae), commonly known as Veludo branco. The in vitro antibacterial activity against the standard bacteria Streptococcus mitis (MIC = 100µg/mL; MBC = 150 µg/mL), Streptococcus mutans (MIC = 200µg/mL; MBC = 220 µg/mL), Streptococcus sanguinis (MIC = 400µg/mL; MBC = 425 µg/mL), Streptococcus sobrinus (MIC = 400µg/mL; MBC = 420 µg/mL) andBacteroides fragilis (MIC = 400µg/mL; MBC = 430 µg/mL), using microdilution broth methods. Protozoans from the trypanosomatid family cause neglected tropical diseases such as trypanosomiasis, for which few drugs are available. In this context, the hydroalcoholic extract of the Tradescantia sillamontana roots was also investigated with regards to the in vitro effects against the trypomastigote forms of theY strain of Trypanosoma cruzi, showing strong activity against this parasite (IC50 = 2.4 µg/mL). When performing cytotoxic activity against fibroblasts LLCMK2 line, the extract showed moderate cytotoxicity (CC50 = 480.37 mg/mL). The results presented for the hydroalcoholic extract of the roots of Tradescantia sillamontana Matuda demonstrated effective antibacterial and trypanocidal activities and were shown to be an alternative source of natural products with activity against T. cruzi and some bacteria of the genus Streptococcus and Bacteroides.


Asunto(s)
Tripanocidas/análisis , Raíces de Plantas/clasificación , Tradescantia/clasificación , /análisis , Antibacterianos/análisis , Commelinaceae/clasificación
4.
PLoS One ; 9(2): e87188, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-24503652

RESUMEN

We present a customized high content (image-based) and high throughput screening algorithm for the quantification of Trypanosoma cruzi infection in host cells. Based solely on DNA staining and single-channel images, the algorithm precisely segments and identifies the nuclei and cytoplasm of mammalian host cells as well as the intracellular parasites infecting the cells. The algorithm outputs statistical parameters including the total number of cells, number of infected cells and the total number of parasites per image, the average number of parasites per infected cell, and the infection ratio (defined as the number of infected cells divided by the total number of cells). Accurate and precise estimation of these parameters allow for both quantification of compound activity against parasites, as well as the compound cytotoxicity, thus eliminating the need for an additional toxicity-assay, hereby reducing screening costs significantly. We validate the performance of the algorithm using two known drugs against T.cruzi: Benznidazole and Nifurtimox. Also, we have checked the performance of the cell detection with manual inspection of the images. Finally, from the titration of the two compounds, we confirm that the algorithm provides the expected half maximal effective concentration (EC50) of the anti-T. cruzi activity.


Asunto(s)
Algoritmos , Ensayos Analíticos de Alto Rendimiento/métodos , Procesamiento de Imagen Asistido por Computador , Parásitos/efectos de los fármacos , Tripanocidas/análisis , Tripanocidas/farmacología , Trypanosoma cruzi/efectos de los fármacos , Animales , Núcleo Celular/efectos de los fármacos , Núcleo Celular/metabolismo , Evaluación Preclínica de Medicamentos , Humanos , Parásitos/citología , Pruebas de Sensibilidad Parasitaria , Reproducibilidad de los Resultados , Trypanosoma cruzi/citología
5.
Acta toxicol. argent ; 21(1): 50-56, jun. 2013. tab
Artículo en Portugués | LILACS | ID: lil-694584

RESUMEN

. Doenças parasitárias infecciosas como leishmaniose e doença de Chagas tem se difundido nas últimas décadas a locais onde antes não se observava sua ocorrência. São consideradas negligenciadas por assolarem países pobres e serem marginalizadas farmacologicamente. O tratamento não apresenta muitas opções de fármacos e estes demonstram relevante toxicidade contribuindo para o aparecimento de diversos efeitos colaterais. A pesquisa com produtos naturais tem se mostrado uma interessante alternativa para a procura por novos fármacos. Lygodium venustum é uma samambaia cosmopolita de hábito lianescente encontrada na encosta na Chapada do Araripe, considerada por algumas populações americanas como planta medicinal para o tratamento de dermatoses, infecções, micoses e tricomoníases. Neste estudo foi avaliada sua atividade anti-parasitária contra Leishmania brasiliensis e Trypanosoma cruzi, bem como sua citotoxicidade através de ensaios n vitro. Foram testadas a fração hexânica e o extrato etanólico obtido das folhas de Lygodium venustum em diferentes concentrações. Para os testes in vitro de T. cruzi, foi utilizado o clone CL-B5 e para Leishmania brasiliensis foram utilizadas formas promastigotas. O ensaio de citotoxicidade foi realizado com linhagens de fbroblastos. L. venustum não apresentou atividade antiparasitária clinicamente relevante na forma de extrato etanólico bruto nem como fração hexânica contra Leishmania. A fração hexânica apresentou uma atividade intermediária contra T. cruzi, porém a concentração de efeito moderado possui citotoxicidade máxima tornando-se inviável para aplicação clínica. Entretanto, a citoxicicidade apresentada poderá ser útil em pesquisas sobre atividade antineoplásica em células tumorais.


Infectious and parasitic diseases like leishmaniasis and Chagas disease have spreading recent decades to places not observed before. They are considered neglected by desolating poor countries and marginalized pharmacologically. There are not many options for the treatment and these drugs have shown signifcant toxicity contributing to the appearance of several side effects. Research on natural products has been shown to be an interesting alternative to the search for new drugs. Lygodium venustum is a cosmopolitan fern with latescence habit found on the Chapada do Araripe, considered by some American popula-tions as a medicinal plant for the treatment of skin diseases, infections, fungal infections and trichomoniasis. This study evaluated its antiparasitic activity against Trypanosoma cruzi and Leishmania brasiliensis, as well as its cytotoxicity through trials in vitro. We tested the ethanolic extract and hexane fraction obtained from the leaves of L. venustum at different concentrations. For in vitro tests of T. cruzi, we used the clone CL-B5 and for L. brasiliensis we used promastigotes. The cytotoxicity assay was performed with strains of fbroblasts. L.venustum showed no antiparasitic activity clinically relevant in the form of crude ethanolic extractor as the hexane fraction against Leishmania. The hexane fraction showed an intermediate activity against T.cruzi, but the concentration of moderate effect has maximum cytotoxicity becoming unfeasible for clinical application. However, the cytotoxicity presented may be useful in research on antineoplastic activity in tumor cells.


Asunto(s)
Helechos/toxicidad , Leishmania braziliensis , Tripanocidas/análisis , Trypanosoma cruzi , Antiparasitarios/análisis
6.
BMC Complement Altern Med ; 13: 48, 2013 Feb 27.
Artículo en Inglés | MEDLINE | ID: mdl-23445637

RESUMEN

BACKGROUND: Malaria, trypanosomiasis and leishmaniasis have an overwhelming impact in the poorest countries in the world due to their prevalence, virulence and drug resistance ability. Currently, there is inadequate armory of drugs for the treatment of malaria, trypanosomiasis and leishmaniasis. This underscores the continuing need for the discovery and development of new anti-protozoal drugs. Consequently, there is an urgent need for research aimed at the discovery and development of new effective and safe anti-plasmodial, anti-trypanosomal and anti-leishmanial drugs. METHODS: Bioassay-guided chromatographic fractionation was employed for the isolation and purification of antiprotozoal alkaloids. RESULTS: The methanol extract from the leaves of Annickia kummeriae from Tanzania exhibited a strong anti-plasmodial activity against the multi-drug resistant Plasmodium falciparum K1 strain (IC50 0.12 ± 0.01 µg/ml, selectivity index (SI) of 250, moderate activity against Trypanosoma brucei rhodesiense STIB 900 strain (IC50 2.50 ± 0.19 µg/ml, SI 12) and mild activity against Leishmania donovani axenic MHOM-ET-67/82 strain (IC50 9.25 ± 0.54 µg/ml, SI 3.2). Bioassay-guided chromatographic fractionation led to the isolation of four pure alkaloids, lysicamine (1), trivalvone (2), palmatine (3), jatrorrhizine (4) and two sets of mixtures of jatrorrhizine (4) with columbamine (5) and palmatine (3) with (-)-tetrahydropalmatine (6). The alkaloids showed low cytotoxicity activity (CC50 30 - >90 µg/ml), strong to moderate anti-plasmodial activity (IC50 0.08 ± 0.001 - 2.4 ± 0.642 µg/ml, SI 1.5-1,154), moderate to weak anti-trypanosomal (IC50 2.80 ± 0.001 - 14.3 ± 0.001 µg/ml, SI 2.3-28.1) and anti-leishmanial activity IC50 2.7 ± 0.001 - 20.4 ± 0.003 µg/ml, SI 1.7-15.6). CONCLUSION: The strong anti-plasmodial activity makes these alkaloids good lead structures for drug development programs.


Asunto(s)
Annonaceae/química , Antiprotozoarios/farmacología , Aporfinas/farmacología , Alcaloides de Berberina/farmacología , Leishmania donovani/efectos de los fármacos , Plasmodium falciparum/efectos de los fármacos , Trypanosoma brucei rhodesiense/efectos de los fármacos , Antimaláricos/análisis , Antimaláricos/farmacología , Antiprotozoarios/análisis , Aporfinas/análisis , Alcaloides de Berberina/análisis , Resistencia a Múltiples Medicamentos/efectos de los fármacos , Concentración 50 Inhibidora , Fitoterapia , Extractos Vegetales/análisis , Extractos Vegetales/farmacología , Hojas de la Planta , Infecciones por Protozoos/tratamiento farmacológico , Tanzanía , Tripanocidas/análisis , Tripanocidas/farmacología
7.
J Pharm Pharmacol ; 63(10): 1346-57, 2011 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-21899551

RESUMEN

OBJECTIVES: The aim of this study was to investigate the flavonoid composition of Scutellaria immaculata and S. ramosissima (Lamiaceae) and the in-vitro biological activity of their extracts and flavonoids. METHODS: The flavonoid composition of S. immaculata (Si) and S. ramosissima (Sr) were analysed using LC-MS. Antimicrobial activity was studied in vitro against a range of bacteria and fungi using diffusion and microdilution methods. Anti-trypanosomal and cell proliferation inhibitory activity of the extracts and flavonoids was assessed using MTT. The antioxidant activity of the flavonoids and extracts were evaluated using DPPH* test. KEY FINDINGS: LC-MS investigation of Si and Sr plants allowed the identification, for the first time, of an additional 9 and 16 flavonoids, respectively. The methanol, chloroform and water extracts from these plants and six flavonoids (scutellarin, chrysin, apigenin, apigenin-7-O-glucoside, cynaroside and pinocembrine) exhibited significant inhibition of cell growth against HeLa, HepG-2 and MCF-7 cells. The chloroform extract of Sr showed potent cytotoxic effects with IC50 (drug concentration which resulted in a 50% reduction in cell viability) values of 9.25 ± 1.07 µg/ml, 12.83 ± 1.49 µg/ml and 17.29 ± 1.27 µg/ml, respectively. The highest anti-trypanosomal effect against T. b. brucei was shown by the chloroform extract of Sr with an IC50 (drug concentration which resulted in a 50% inhibition of the biological activity) of 61 µg/ml. The pure flavonoids showed an IC50 range between 3 and 29 µm, with cynaroside as the most active compound with an IC50 value of 3.961 ± 0.133 µm. The chloroform extract of Sr has potent antimicrobial activity against Streptococcus pyogenes (minimum inhibitory concentration, MIC = 0.03 mg/ml). Pinocembrine exhibited a strong activity against the all bacteria except Escherichia coli and yeasts. Water extracts of Sr and Si exhibited potent antioxidant activity with IC50 values of 5.62 ± 0.51 µg/ml and 3.48 ± 0.02 µg/ml, respectively. Scutellarin exerted stronger antioxidant activity than other flavonoids. CONCLUSIONS: This is the first study reporting an in-vitro biological investigation for Si and Sr. Especially the chloroform extract of Sr showed potent anticancer and antimicrobial activity. Cynaroside had a highly selective and strong cytotoxicity against T. b. brucei while showing only mild effects against cancer cells.


Asunto(s)
Antiinfecciosos/farmacología , Antineoplásicos Fitogénicos/uso terapéutico , Antioxidantes/farmacología , Flavonoides/farmacología , Extractos Vegetales/farmacología , Scutellaria/química , Tripanocidas/farmacología , Antiinfecciosos/análisis , Antineoplásicos Fitogénicos/análisis , Antineoplásicos Fitogénicos/farmacología , Apigenina/análisis , Apigenina/farmacología , Bacterias/efectos de los fármacos , Compuestos de Bifenilo/metabolismo , Flavonoides/análisis , Glucósidos/análisis , Glucósidos/farmacología , Glucósidos/uso terapéutico , Glucuronatos/análisis , Glucuronatos/farmacología , Células HeLa , Humanos , Concentración 50 Inhibidora , Luteolina/análisis , Luteolina/farmacología , Luteolina/uso terapéutico , Neoplasias/tratamiento farmacológico , Fitoterapia , Picratos/metabolismo , Componentes Aéreos de las Plantas , Extractos Vegetales/química , Raíces de Plantas , Tripanocidas/análisis , Trypanosoma brucei brucei/efectos de los fármacos , Levaduras/efectos de los fármacos
8.
Nat Prod Commun ; 6(11): 1637-44, 2011 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-22224278

RESUMEN

Four new prenylated isoflavones, rhynedulins A-C (1-3) and rhynedulinal (4), were isolated by bioassay-guided fractionation of the dichloromethane bark extract of Rhynchosia edulis. Five previously described compounds, scandenal, ulexin B, cajanone, cajanin, and cyclochandalone, were also isolated. These isoflavonoids showed weak inhibitory activity towards rhodesain, the major cathepsin-L like protease in Trypanosoma brucei. They also have weak antiproliferative activity towards MCF-7 cells.


Asunto(s)
Antineoplásicos Fitogénicos/análisis , Cisteína Endopeptidasas/química , Fabaceae/química , Isoflavonas/aislamiento & purificación , Tripanocidas/análisis , Línea Celular Tumoral , Humanos , Isoflavonas/química , Espectroscopía de Resonancia Magnética , Estructura Molecular , Corteza de la Planta/química , Extractos Vegetales/química
9.
Phytomedicine ; 17(5): 369-74, 2010 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-19683909

RESUMEN

Artemisia species are one of the many traditional medicinal plants of Ethiopia used for the treatment of infectious and non-infectious health problems. In the present study, eight extracts prepared from leaves and aerial parts of four Artemisia species (Artemisia absinthium, A. abyssinica, A. afra, and A. annua) growing in Ethiopia were tested in vitro against bloodstream forms of Trypanosoma brucei brucei. The most active extract was the dichloromethane extract from aerial parts of A. abyssinica with an IC(50) value of 19.13 microg/ml. A selectivity index (SI) of 8.24 was obtained with HL-60 cells treated with the same extract. Artemisinin, the best known antimalarial compound from A. annua showed antitrypanosomal activity with an IC(50) value of 35.91 microg/ml and with a selectivity index of 2.44. The dichloromethane extracts of the four species were further investigated for their volatile components using GLC/MS. Camphor was detected in the four species and was found to be the principal compound (38.73%) of A. absinthium extract. Octa-3,5-diene-2,7-dione, 4,5-dihydroxy was detected in three species except in A. afra and was present as the main volatile component (54.95%) of A. abyssinica. Epoxylinalool was detected only in A. afra and was the principal component (29.10%) of dichloromethane extract of the plant. Deoxyqinghaosu was only present in A. annua and absent in the other three Artemisia species. Deoxyqinghaosu was the principal volatile component (20.44%) of the dichloromethane extract of A. annua. In conclusion, the dichloromethane extract from aerial part of A. abyssinica should be considered for further study for the treatment of trypanosomiasis.


Asunto(s)
Artemisia/química , Citotoxinas/farmacología , Aceites Volátiles/farmacología , Extractos Vegetales/farmacología , Tripanocidas/farmacología , Trypanosoma brucei brucei/efectos de los fármacos , Citotoxinas/análisis , Etiopía , Células HL-60 , Humanos , Concentración 50 Inhibidora , Medicinas Tradicionales Africanas , Aceites Volátiles/análisis , Pruebas de Sensibilidad Parasitaria , Componentes Aéreos de las Plantas , Extractos Vegetales/química , Hojas de la Planta , Tripanocidas/análisis
10.
Afr J Tradit Complement Altern Med ; 7(3): 207-13, 2010 Apr 03.
Artículo en Inglés | MEDLINE | ID: mdl-21461147

RESUMEN

Organic extracts of the leaves of Azadirachta indica A. Juss. yielded ten antitrypanosomal terpenoids. Three of these (1-3), are novel and are derivatives of nimbolide and nimbin. They were extracted from chloroform fraction of methanol extract. These compounds were found to exhibit strong antitrypanosomal activities against Trypanosoma brucei rhodesiense with MIC values ranging of 6.9, 15.6 and 7.8 µg/ml respectively and were more active than Cymerlarsan (a standard drug), which had an MIC value of 187.5 µg/ml when tested against T. b. rhodesiense. The structures were elucidated by spectroscopic methods including; NMR, MS, UV and IR.


Asunto(s)
Azadirachta/química , Extractos Vegetales/farmacología , Plantas Medicinales/química , Tripanocidas/farmacología , Trypanosoma brucei rhodesiense/efectos de los fármacos , Tripanosomiasis Africana/tratamiento farmacológico , Arsenicales/uso terapéutico , Cromatografía , Humanos , Limoninas/química , Tripanocidas/análisis , Tripanocidas/uso terapéutico
11.
J Ethnopharmacol ; 37(2): 159-64, 1992 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-1434690

RESUMEN

The stem barks of Pera benensis are employed by the Chimane Indians in the Bolivian Amazonia as treatment of cutaneous leishmaniasis caused by the protozoan Leishmania braziliensis. The chloroform extracts containing quinones were found active against the promastigote forms of Leishmania and the epimastigote forms of Trypanosoma cruzi at 10 micrograms ml-1. The activity guided fractionation of the extract by chromatography afforded active compounds. Their structures were elucidated, by spectral and chemical studies, as known naphthoquinones, plumbagin, 3,3'-biplumbagin, 8-8'-biplumbagin, and triterpene, lupeol. The activity in vitro of each compound was evaluated against 5 strains of Leishmania (promastigote), 6 strains of Trypanosoma cruzi (epimastigote) and the intracellular form (amastigote) of Leishmania amazonensis. The baseline drugs used were Glucantime and pentamidine (Leishmania spp.), nifurtimox and benznidazole (T. cruzi). Plumbagin was the most active compound in vitro. This study has demonstrated that Pera benensis, a medicinal plant used in folk medicine, is an efficient treatment of cutaneous leishmaniasis.


Asunto(s)
Leishmaniasis Cutánea/tratamiento farmacológico , Medicina Tradicional , Plantas Medicinales/química , Animales , Bolivia , Enfermedad de Chagas/tratamiento farmacológico , Enfermedad de Chagas/parasitología , Leishmania/efectos de los fármacos , Ratones , Naftoquinonas/farmacología , Espectrofotometría Ultravioleta , Tripanocidas/análisis , Tripanocidas/aislamiento & purificación , Trypanosoma cruzi/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA